Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00039091
Status:
TERMINATED
Last Update Posted:
2018-09-05
First Post:
2002-06-06
Brief Title:
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer Melanoma Acute Myeloid Leukemia Myelodysplastic Syndrome or Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Non-small Cell Lung Cancer |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Atypical Chronic Myeloid Leukemia BCR-ABL1 Negative |
| MyelodysplasticMyeloproliferative Neoplasm Unclassifiable |
| Previously Treated Myelodysplastic Syndromes |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Melanoma |
| Recurrent Non-small Cell Lung Cancer |
| Recurrent Ovarian Epithelial Cancer |
| Stage IV Melanoma |
Keywords: